ALKEM vs BIOCON vs GRANULES vs NATCOPHARM: which stock is better?
Granules India Limited (GRANULES) has the highest StockLens rating in this group at 7.5/10 (Good).
| Metric | ALKEM | BIOCON | GRANULES | NATCOPHARM |
|---|---|---|---|---|
| Overall rating | 5.7/10 (Average) | 2.4/10 (Poor) | 7.5/10 (Good) | 6.2/10 (Average) |
| Long-term view | Neutral (watchlist) | Avoid | Strong long-term candidate | Neutral (watchlist) |
| Trade bias | Strong short | Strong short | Strong long | Strong short |
| Share price | ₹5,175.00 | ₹359.40 | ₹815.50 | ₹822.90 |
| Market cap | ₹61,875 Cr | ₹58,861 Cr | ₹22,245 Cr | ₹16,143 Cr |
| P/E | 29.9 | 120.6 | 28.5 | 17.9 |
| Return on equity | 14.2% | 1.0% | 13.5% | – |
| Debt / equity | 0.15 | 0.42 | 0.17 | 0.08 |
| Revenue growth (YoY) | +13.8% | +2.2% | +20.3% | -44.7% |
| 1-year return | -8.7% | -6.0% | +47.0% | +3.0% |
Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.